Reply by Authors

Affiliations

¹ Department of Urology, University of Texas Health, San Antonio, Texas.
² Department of Urology, University of Washington, Seattle, Washington.
³ Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York.
⁴ Department of Surgery/Division of Urology, Cedars-Sinai Medical Center, Los Angeles, California.
⁵ Dolph Briscoe Jr Library, University of Texas Health, San Antonio, Texas.
⁶ Department of Medical Oncology, Mays Cancer Centre, San Antonio, Texas.

Comment

Harshit Garg et al. J Urol. 2022 Sep.

. 2022 Sep;208(3):559.

doi: 10.1097/JU.0000000000002829.02. Epub 2022 Sep 1.

¹ Department of Urology, University of Texas Health, San Antonio, Texas.
² Department of Urology, University of Washington, Seattle, Washington.
³ Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York.
⁴ Department of Surgery/Division of Urology, Cedars-Sinai Medical Center, Los Angeles, California.
⁵ Dolph Briscoe Jr Library, University of Texas Health, San Antonio, Texas.
⁶ Department of Medical Oncology, Mays Cancer Centre, San Antonio, Texas.

No abstract available

Comment on

Editorial Comment.
Rivera KV, Schulman A. Rivera KV, et al. J Urol. 2022 Sep;208(3):558-559. doi: 10.1097/JU.0000000000002829.01. Epub 2022 Sep 1. J Urol. 2022. PMID: 35942784 No abstract available.